Red blood cells stored for increasing periods produce progressive impairments in nitric oxide-mediated vasodilation

Transfusion

Volumn 53, Issue 11, 2013, Pages 2619-2628

  Alexander, Jason T ^a   El Ali, Alexander M ^a   Newman, James L ^a   Karatela, Sulaiman ^a   Predmore, Benjamin L ^a   Lefer, David J ^a   Sutliff, Roy L ^a   Roback, John D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; HEMOGLOBIN; METHACHOLINE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD STORAGE; CONTROLLED STUDY; ERYTHROCYTE; EX VIVO STUDY; HEMOGLOBIN BLOOD LEVEL; LEISURE; MEAN CORPUSCULAR HEMOGLOBIN; NONHUMAN; RAT; SUPERNATANT; VASCULAR RING; VASODILATATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD PRESERVATION; ERYTHROCYTES; HEMOGLOBINS; HUMANS; METHACHOLINE CHLORIDE; NITRIC OXIDE; RATS; TIME FACTORS; VASODILATION;

EID: 84887818292     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12111     Document Type: Article

References (52)

1. Wier LM, Pfuntner A, Maeda J, Stranges E, Ryan K, Jagadish P, Collins Sharp B, Elixhauser A,. Health Care Cost and Utilization Project (HCUP) facts and figures, statistics on hospital-based care in the United States, 2009, Exhibit 3.1. Most frequent all-listed procedures. [cited 2013 Jan 14]. Available from: URL: http://www.hcup-us.ahrq.gov/reports/factsandfigures/2009/exhibit3-1. jsp
2. Dumont LJ, AuBuchon JP,. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion 2008; 48: 1053-1060.
3. Zimrin AB, Hess JR,. Current issues relating to the transfusion of stored red blood cells. Vox Sang 2009; 96: 93-103.
4. Roback JD,. Vascular effects of the red cell storage lesion. Hematology Am Soc Hematol Educ Program 2011; 2011: 475-479.
5. Hovav T, Yedgar S, Manny N, Barshtein G,. Alteration of red cell aggregability and shape during blood storage. Transfusion 1999; 39: 277-281.
6. Bennett-Guerrero E, Veldman TH, Doctor A, Telen MJ, Ortel TL, Reid TS, Mulherin MA, Zhu H, Buck RD, Califf RM, McMahon TJ,. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A 2007; 104: 17063-17068.
7. Tinmouth A, Fergusson D, Yee IC, Hébert PC,; ABLE Investigators, Canadian Critical Care Trials Group. Clinical consequences of red cell storage in the critically ill. Transfusion 2006; 46: 2014-2027.
8. Wang D, Sun J, Solomon SB, Klein HG, Natanson C,. Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion 2012; 52: 1184-1195.
9. Fergusson DA, Hébert P, Hogan DL, LeBel L, Rouvinez-Bouali N, Smyth JA, Sankaran K, Tinmouth A, Blajchman MA, Kovacs L, Lachance C, Lee S, Walker CR, Hutton B, Ducharme R, Balchin K, Ramsay T, Ford JC, Kakadekar A, Ramesh K, Shapiro S,. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA 2012; 308: 1443-1451.
10. Steiner ME, Assmann SF, Levy JH, Marshall J, Pulkrabek S, Sloan SR, Triulzi D, Stowell CP,. Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci 2010; 43: 107-116.
11. Lacroix J, Hébert P, Fergusson D, Tinmouth A, Blajchman MA, Callum J, Cook D, Marshall JC, McIntyre L, Turgeon AF,; ABLE study group. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev 2011; 25: 197-205.
12. Koch CG,. The Red Cell Storage Duration and Outcomes in Cardic Surgery study. Clinical Trials.gov 2012. [cited 2013 Jan 14]. Available from: URL: http://clinicaltrials.gov/ct2/show/NCT00458783
13. Allen BW, Piantadosi CA,. How do red blood cells cause hypoxic vasodilation? The SNO-hemoglobin paradigm. Am J Physiol Heart Circ Physiol 2006; 291: H1507-1512.
14. Crawford JH, Isbell TS, Huang Z, Shiva S, Chacko BK, Schechter AN, Darley-Usmar VM, Kerby JD, Lang JD Jr, Kraus D, Ho C, Gladwin MT, Patel RP,. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 2006; 107: 566-574.
15. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA,. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218: 739-749.
16. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J,. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A 1992; 89: 444-448.
17. Pawloski JR, Stamler JS,. Nitric oxide in RBCs. Transfusion 2002; 42: 1603-1609.
18. Singel DJ, Stamler JS,. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu Rev Physiol 2005; 67: 99-145.
19. Reynolds JD, Ahearn GS, Angelo M, Zhang J, Cobb F, Stamler JS,. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A 2007; 104: 17058-17062.
20. Huang KT, Keszler A, Patel N, Patel RP, Gladwin MT, Kim-Shapiro DB, Hogg N,. The reaction between nitrite and deoxyhemoglobin. Reassessment of reaction kinetics and stoichiometry. J Biol Chem 2005; 280: 31126-31131.
21. Huang Z, Shiva S, Kim-Shapiro DB, Patel RP, Ringwood LA, Irby CE, Huang KT, Ho C, Hogg N, Schechter AN, Gladwin MT,. Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest 2005; 115: 2099-2107.
22. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO 3rd, Gladwin MT,. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003; 9: 1498-1505.
23. Chen K, Popel AS,. Theoretical analysis of biochemical pathways of nitric oxide release from vascular endothelial cells. Free Radic Biol Med 2006; 41: 668-680.
24. Chen K, Piknova B, Pittman RN, Schechter AN, Popel AS,. Nitric oxide from nitrite reduction by hemoglobin in the plasma and erythrocytes. Nitric Oxide 2008; 18: 47-60.
25. Chen K, Pittman RN, Popel AS,. Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective. Antioxid Redox Signal 2008; 10: 1185-1198.
26. Ellsworth ML,. The red blood cell as an oxygen sensor: what is the evidence? Acta Physiol Scand 2000; 168: 551-559.
27. Ellsworth ML,. Red blood cell-derived ATP as a regulator of skeletal muscle perfusion. Med Sci Sports Exerc 2004; 36: 35-41.
28. Ellsworth ML, Forrester T, Ellis CG, Dietrich HH,. The erythrocyte as a regulator of vascular tone. Am J Physiol 1995; 269 (6 Pt 2): H2155-2161.
29. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ,. ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Physiol 1996; 271 (6 Pt 2): H2717-2722.
30. Zhu H, Zennadi R, Xu BX, Eu JP, Torok JA, Telen MJ, McMahon TJ,. Impaired adenosine-5′-triphosphate release from red blood cells promotes their adhesion to endothelial cells: a mechanism of hypoxemia after transfusion. Crit Care Med 2011; 39: 2478-2486.
31. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT,. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002; 8: 1383-1389.
32. Rother RP, Bell L, Hillmen P, Gladwin MT,. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293: 1653-1662.
33. Kim-Shapiro DB, Lee J, Gladwin MT,. Storage lesion: role of red blood cell breakdown. Transfusion 2011; 51: 844-851.
34. Donadee C, Raat NJ, Kanias T, Tejero J, Lee JS, Kelley EE, Zhao X, Liu C, Reynolds H, Azarov I, Frizzell S, Meyer EM, Donnenberg AD, Qu L, Triulzi D, Kim-Shapiro DB, Gladwin MT,. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011; 124: 465-476.
35. Kline ER, Bassit L, Hernandez-Santiago BI, Detorio MA, Liang B, Kleinhenz DJ, Walp ER, Dikalov S, Jones DP, Schinazi RF, Sutliff RL,. Long-term exposure to AZT, but not d4T, increases endothelial cell oxidative stress and mitochondrial dysfunction. Cardiovasc Toxicol 2009; 9: 1-12.
36. Bryan NS, Calvert JW, Gundewar S, Lefer DJ,. Dietary nitrite restores NO homeostasis and is cardioprotective in endothelial nitric oxide synthase-deficient mice. Free Radic Biol Med 2008; 45: 468-474.
37. Hess JR, Rugg N, Knapp AD, Gormas JF, Hill HR, Oliver CK, Lippert LE, Greenwalt TJ,. The role of electrolytes and pH in RBC ASs. Transfusion 2001; 41: 1045-1051.
38. Hess JR, Rugg N, Joines AD, Gormas JF, Pratt PG, Silberstein EB, Greenwalt TJ,. Buffering and dilution in red blood cell storage. Transfusion 2006; 46: 50-54.
39. Yoshida T, AuBuchon JP, Dumont LJ, Gorham JD, Gifford SC, Foster KY, Bitensky MW,. The effects of additive solution pH and metabolic rejuvenation on anaerobic storage of red cells. Transfusion 2008; 48: 2096-2105.
40. Meyer EK, Dumont DF, Baker S, Dumont LJ,. Rejuvenation capacity of red blood cells in additive solutions over long-term storage. Transfusion 2011; 51: 1574-1579.
41. Roback JD, Neuman RB, Quyyumi A, Sutliff R,. Insufficient nitric oxide bioavailability: a hypothesis to explain adverse effects of red blood cell transfusion. Transfusion 2011; 51: 859-866.
42. Glynn SA,. The red blood cell storage lesion: a method to the madness. Transfusion 2010; 50: 1164-1169.
43. Kanias T, Gladwin MT,. Nitric oxide, hemolysis, and the red blood cell storage lesion: interactions between transfusion, donor, and recipient. Transfusion 2012; 52: 1388-1392.
44. Spinella PC, Doctor A, Blumberg N, Holcomb JB,. Does the storage duration of blood products affect outcomes in critically ill patients? Transfusion 2011; 51: 1644-1650.
45. Yu B, Lei C, Baron DM, Steinbicker AU, Bloch KD, Zapol WM,. Diabetes augments and inhaled nitric oxide prevents the adverse hemodynamic effects of transfusing syngeneic stored blood in mice. Transfusion 2012; 52: 1410-1422.
46. Bunn HF, Nathan DG, Dover GJ, Hebbel RP, Platt OS, Rosse WF, Ware RE,. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood 2010; 116: 687-692.
47. Stapley R, Owusu BY, Brandon A, Cusick M, Rodriguez C, Marques MB, Kerby JD, Barnum SR, Weinberg JA, Lancaster JR Jr, Patel RP,. Erythrocyte storage increases rates of NO and nitrite scavenging: implications for transfusion-related toxicity. Biochem J 2012; 446: 499-508.
48. Villar IC, Francis S, Webb A, Hobbs AJ, Ahluwalia A,. Novel aspects of endothelium-dependent regulation of vascular tone. Kidney Int 2006; 70: 840-853.
49. Walford G, Loscalzo J,. Nitric oxide in vascular biology. J Thromb Haemost 2003; 1: 2112-2118.
50. Chataigneau T, Félétou M, Huang PL, Fishman MC, Duhault J, Vanhoutte PM,. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol 1999; 126: 219-226.
51. Liu LH, Paul RJ, Sutliff RL, Miller ML, Lorenz JN, Pun RY, Duffy JJ, Doetschman T, Kimura Y, MacLennan DH, Hoying JB, Shull GE,. Defective endothelium-dependent relaxation of vascular smooth muscle and endothelial cell Ca2+ signaling in mice lacking sarco(endo)plasmic reticulum Ca2+-ATPase isoform 3. J Biol Chem 1997; 272: 30538-30545.
52. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM Jr, Gladwin MT,. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005; 294: 81-90.